How many times is it considered normal to experience hematuria in a year for someone with IgA?

Update Date: Source: Network

There is no definitive normal range for the number of times IgA nephropathy patients experience hematuria within a year. This is because each patient's condition and physical status vary, leading to differences in the specific frequency. IgA nephropathy is a chronic kidney disease with common symptoms including recurrent gross or microscopic hematuria, proteinuria, edema, and hypertension. Although the exact cause is unknown, it may be related to factors such as genetics, infection, and immunity. Patients need regular follow-ups to monitor the progression of their condition.

1. Warning Sign of Disease Progression: If IgA nephropathy patients experience hematuria more than 3-4 times a year, it may indicate that the disease is worsening. Prompt medical attention is crucial at this point. The doctor will conduct further examinations based on the specific situation and develop a corresponding treatment plan, which may include medication and dietary adjustments.

2. Importance of Good Lifestyle Habits: IgA nephropathy patients need to maintain good lifestyle habits and avoid adverse factors such as excessive fatigue and emotional excitement. A healthy lifestyle not only helps slow down the progression of the disease but also enhances overall quality of life.

3. Necessity of Regular Follow-ups: Regular follow-ups are crucial for IgA nephropathy patients. Through regular check-ups, doctors can promptly detect changes in the condition and take corresponding measures. This not only helps patients better manage their condition but also allows for adjustment of the treatment plan when necessary. The frequency of hematuria in IgA nephropathy patients varies from person to person, with no fixed standard. The most important thing is to take appropriate measures for management and treatment based on their own condition and medical advice. Maintaining good lifestyle habits and regular check-ups can effectively help patients cope with this chronic disease.